Literature DB >> 9716900

Langerhans cell migration in murine cutaneous leishmaniasis: regulation by tumor necrosis factor alpha, interleukin-1 beta, and macrophage inflammatory protein-1 alpha.

J Arnoldi1, H Moll.   

Abstract

After intradermal infection of mice with the obligatory intracellular parasite Leishmania major, Langerhans cells (LC) are intimately involved in the induction of the primary T-cell immune response. LC can phagocytose Leishmania and transport ingested parasites from the infected skin to the regional lymph nodes. Since TNF alpha and IL-1 beta have been shown to induce LC migration after epicutaneous exposure to skin-sensitizing chemicals, we investigated the involvement of both cytokines in the migration of Leishmania-infected LC. In addition, the relevance of two chemokines of the beta subfamily, macrophage inflammatory protein 1 alpha (MIP-1 alpha) and macrophage chemoattractant protein 1 (MCP-1), was analyzed. In vivo depletion of TNF alpha significantly reduced the amount of infected LC and the parasite load in the draining lymph nodes. Administration of recombinant TNF alpha caused the reverse effect. In contrast, the depletion of IL-1 beta enhanced the parasite-induced LC migration, whereas treatment with recombinant IL-1 beta, as well as recombinant MIP-1 alpha, reduced the rate of infected LC in the lymph nodes. MCP-1 did not influence LC migration. Our data demonstrate that TNF alpha and IL-1 beta are regulating the LC-mediated transport of Leishmania and also provide evidence for the involvement of macrophage attractant chemokines in this process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9716900      PMCID: PMC2276000          DOI: 10.1155/1998/21095

Source DB:  PubMed          Journal:  Dev Immunol        ISSN: 1026-7905


  7 in total

1.  Leishmania major promastigotes inhibit dendritic cell motility in vitro.

Authors:  Heather Jebbari; Andrew J Stagg; Robert N Davidson; Stella C Knight
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Feasibility of Hepatitis B Vaccination by Microneedle Patch: Cellular and Humoral Immunity Studies in Rhesus Macaques.

Authors:  Youkyung H Choi; Monica B Perez-Cuevas; Maja Kodani; Xiugen Zhang; Mark R Prausnitz; Saleem Kamili; Siobhan M O'Connor
Journal:  J Infect Dis       Date:  2019-11-06       Impact factor: 5.226

3.  Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells.

Authors:  A Ponte-Sucre; D Heise; H Moll
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

4.  Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis.

Authors:  Jiaxiang Ji; Jiaren Sun; Lynn Soong
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

5.  Local response to microneedle-based influenza immunization in the skin.

Authors:  Maria del Pilar Martin; William C Weldon; Vladimir G Zarnitsyn; Dimitrios G Koutsonanos; Hamed Akbari; Ioanna Skountzou; Joshy Jacob; Mark R Prausnitz; Richard W Compans
Journal:  mBio       Date:  2012-03-06       Impact factor: 7.867

6.  CD207+ Langerhans cells constitute a minor population of skin-derived antigen-presenting cells in the draining lymph node following exposure to Schistosoma mansoni.

Authors:  Supeecha Kumkate; Gavin R Jenkins; Ross A Paveley; Karen G Hogg; Adrian P Mountford
Journal:  Int J Parasitol       Date:  2006-11-27       Impact factor: 3.981

7.  Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection.

Authors:  V Angeli; C Faveeuw; O Roye; J Fontaine; E Teissier; A Capron; I Wolowczuk; M Capron; F Trottein
Journal:  J Exp Med       Date:  2001-05-21       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.